RENVI, created in 2008 (United States), from 585 sister brands and 17478 competing brands. RENVI is owned by ASTRAZENECA, listed on the stock exchange of London The International Securities Identification Number (ISIN) of ASTRAZENECA is GB0009895292. The sector of RENVI is Drug Manufacturers.